Effects of cisplatin on human thyrocytes in monolayer or follicle culture

J Mol Endocrinol. 1992 Jun;8(3):243-8. doi: 10.1677/jme.0.0080243.

Abstract

Cis-diamminedichloroplatinum (II) (cisplatin) is a widely used anticancer drug which induces many side-effects, but its action on the thyroid gland is still unknown. We have investigated the effects of this drug on human thyrocytes cultured in monolayers or in follicles and stimulated with 200 microU TSH/ml. After 72 h in culture, different concentrations of cisplatin (15, 30 and 75 microM) caused partial or total inhibition of cyclic AMP (cAMP), thyroglobulin (Tg) and tri-iodothyronine (T3) production, whereas thyroxine levels increased in the medium of thyrocytes cultured as follicles. Small doses of the drug did not affect thyrocyte production. Decreases in neutral-red uptake by thyroid cells and in intracellular lactate dehydrogenase, alpha-hydroxybutyryldehydrogenase and creatine phosphokinase activities were induced by 30 and 75 microM cisplatin. These data show that high concentrations of cisplatin had a cytotoxic effect on thyrocytes. Cisplatin also induced inhibition of the production of cAMP, Tg and T3.

MeSH terms

  • Cells, Cultured
  • Cisplatin / pharmacology*
  • Cisplatin / toxicity
  • Collagen
  • Cyclic AMP / metabolism
  • Humans
  • Thyroid Gland / cytology
  • Thyroid Gland / drug effects*
  • Thyrotropin / physiology
  • Thyroxine / physiology

Substances

  • Thyrotropin
  • Collagen
  • Cyclic AMP
  • Cisplatin
  • Thyroxine